Stocktoria
DiaMedica Therapeutics Inc. DMAC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2008-01-04
DiaMedica Therapeutics Inc. statistics & valuation
Market cap$352.9M
P / B6.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -53.4% | -52.7% | -35.8% | -39.8% | -29.8% |
| Return on equity | -58.4% | -60.0% | -38.0% | -43.0% | -30.9% |
| Current ratio | 11.81 | 8.28 | 19.27 | 15.61 | 29.82 |
Source: SEC EDGAR filings · CIK 0001401040 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.